| 1 |
Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: a complication of massive obesity [J]. Ann Intern Med, 1974, 81(4): 440-447.
|
| 2 |
Cohen AH. Massive obesity and the kidney. A morphologic and statistical study [J]. Am J Pathol, 1975, 81(1): 117-130.
|
| 3 |
王庆文. 肥胖相关性肾病的临床表现[J]. 肾脏病与透析肾移植志，2005，14(4): 343-344.
|
| 4 |
Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic [J]. Kidney Int, 2001, 59(4): 1498-1509.
|
| 5 |
陈慧梅，刘志红，李世军，等. 肥胖相关性肾病患者流行病学资料及临床病理特征分析[J]. 肾脏病与透析肾移植杂志，2008，17(1): 30-37.
|
| 6 |
Darouich S, Goucha R, Jaafoura MH, et al. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis [J]. Ultrastruct Pathol, 2011, 35(4): 176-182.
|
| 7 |
Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity [J]. Am J Physiol Renal Physiol, 2000, 278(5): F817-F822.
|
| 8 |
Durvasula RV, Petermann AT, Hiromura K, et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain [J]. Kidney Int, 2004, 65(1): 30-39.
|
| 9 |
Yadav A, Vallabu S, Arora S, et al. ANG II promotes autophagy in podocytes [J]. Am J Physiol Cell Physiol, 2010, 299(2): C488-C496.
|
| 10 |
Lee H S. Mechanisms and consequences of TGF-ss overexpression by podocytes in progressive podocyte disease [J]. Cell Tissue Res, 2012, 347(1): 129-140.
|
| 11 |
Hoeppner LH, Phoenix KN, Clark K J, et al. Revealing the role of phospholipase Cbeta3 in the regulation of VEGF-induced vascular permeability [J]. Blood, 2012, 120(11): 2167-2173.
|
| 12 |
Friederich-Persson M, Thorn E, Hansell P, et al. Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress [J]. Hypertension, 2013, 62(5): 914-919.
|
| 13 |
Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function [J]. Kidney Int, 2008, 73(8): 947-955.
|
| 14 |
Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts [J]. Kidney Int, 2000, 58(6): 2351-2366.
|
| 15 |
Eckardt KU, Bernhardt WM, Weidemann A, et al. Role of hypoxia in the pathogenesis of renal disease [J]. Kidney Int, 2005, 68(Suppl 99): S46-S51.
|
| 16 |
Welsh GI, Hale LJ, Eremina V, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function [J]. Cell Metab, 2010, 12(4): 329-340.
|
| 17 |
De Cosmo S, Menzaghi C, Prudente S, et al. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence [J]. Nephrol Dial Transplant, 2013, 28(1): 29-36.
|
| 18 |
范亚平，蒋季杰. 肥胖相关肾病[J]. 中华肾脏病杂志，2007，23(4): 267-270.
|
| 19 |
Sainz N, Barrenetxe J, Moreno-Aliaga MJ, et al. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin [J]. Metabolism, 2015, 64(1): 35-46.
|
| 20 |
Nasrallah MP, Ziyadeh FN. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney [J]. Semin Nephrol, 2013, 33(1): 54-65.
|
| 21 |
Wolf G, Ziyadeh FN. Leptin and renal fibrosis [J]. Contrib Nephrol, 2006, 151: 175-183.
|
| 22 |
Lambert EA, Straznicky NE, Dixon JB, et al. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? [J]. Am J Physiol Heart Circ Physiol, 2015, 309(2): H244-H258.
|
| 23 |
Redon J, Lurbe E. The kidney in obesity [J]. Curr Hypertens Rep, 2015, 17(6): 555.
|
| 24 |
Morales E, Valero MA, Leon M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies [J]. Am J Kidney Dis, 2003, 41(2): 319-327.
|
| 25 |
Miyazaki Y, Cersosimo E, Triplitt C, et al. Rosiglitazone decreases albuminuria in type 2 diabetic patients [J]. Kidney Int, 2007, 72(11): 1367-1373.
|
| 26 |
Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis [J]. Nephrol Dial Transplant, 2001, 16(9): 1790-1798.
|